Introduction and objectives The cardiac sequelae of SARS-CoV-2 infection are still poorly
documented. We conducted a cross-sectional study in healthcare workers to report evidence …

(1) Background: Coronavirus infection (Covid-19) has emerged as a severe medical
condition, associated with high pulmonary morbidity and often with cardiovascular (CV) …

Background COVID‐19 may present with a variety of cardiovascular manifestations, and
elevations of biomarkers reflecting myocardial injury and stress are prevalent. SARS‐CoV‐2 …

Background Besides the lungs, coronavirus disease 2019 (COVID-19) can affect the
cardiovascular, digestive, urinary, hepatic, and central nervous systems. Other than its short …

Background Understanding the pathophysiology of respiratory failure (ARDS) in coronavirus
disease 2019 (COVID-19) patients is of utmost importance for the development of …

Cardiovascular disease (CVD) is the most common co-morbidity associated with COVID-19
and the fatality rate in COVID-19 patients with CVD is higher compared to other …

COVID-19 has been associated with cardiovascular consequences, including myocardial
infarction, thromboembolic events, arrhythmia, and heart failure. Numerous overlapping …

Clinical manifestations of COVID-19 affect many organs, including the heart. Cardiovascular
disease is a dominant comorbidity and prognostic factors predicting risk for critical courses …

BACKGROUND Prolonged symptoms after SARS-CoV-2 infection are well documented.
However, which factors influence development of long-term symptoms, how symptoms vary …

Background The negative impact of long COVID on social life and human health is
increasingly prominent, and the elevated risk of cardiovascular disease in patients …